Skip to content

 

Newsroom

Newsroom

  • June 12, 2017 - Vertos Medical Secures $28 Million In Latest Round Of Funding
    Vertos Medical Inc., a leader in the minimally invasive treatment of lumbar spinal stenosis (LSS), announced today it has completed a $28 million financing round. New investor, MVM Life Science Partners LLP, led the round with participation from existing investors Leerink Revelation Partners, Pitango Venture Capital, ONSET Ventures, and Aweida Venture Partners. Proceeds of the financing will be used to expand commercialization of the company's proprietary mild procedure, a clinically proven outpatient procedure that removes the cause of the stenosis through a portal the size of a baby aspirin and requires no implants, no general anesthesia, no stitches, and no overnight hospital stay.
  • March 7, 2017 - Vertos Medical's mild Procedure Receives Broad Coverage From Centers for Medicare & Medicaid Services
    Vertos Medical, a medical device company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), has received national coverage for its mild Procedure through a recently approved study under the Centers for Medicare & Medicaid Services' (CMS) Coverage with Evidence Development (CED) Program. A clinically proven outpatient procedure performed through a portal the size of a baby aspirin, mild requires no stitches, no general anesthesia, no implants, and no overnight hospital stay.
  • June 19, 2013 - Vertos Medical Raises $23 Million in Series E Financing
    Vertos Medical Inc., which has pioneered the mild procedure - a safe, outpatient procedure that can help patients diagnosed with lumbar spinal stenosis (LSS) stand longer and walk farther with less pain - announced today that it has closed nearly $23 million in financing. The proceeds will be used to fund U.S. commercial expansion and the launch of mild in European markets.
  • October 17, 2012 - Back Pain Treatment Called mild Hits Milestone
    The mild procedure, an innovative outpatient back-pain treatment, has passed a major milestone - more than 12,000 patients have received the treatment across the U.S. In addition, a growing number of clinical studies, including a recent trial published by the prestigious Cleveland Clinic, show that mild helps patients stand longer and walk farther with less pain over an extended period.
  • July 11, 2011 - Vertos mild One-Year Post-Study Follow-up Data Published in Pain Practice Journal
    Medical device company Vertos Medical Inc. has announced that one-year post-study follow-up data on its mild procedure for lumbar spinal stenosis (LSS) have been published in the peer-reviewed journal Pain Practice. In “Long Term Results of Percutaneous Lumbar Decompression mild for Spinal Stenosis,” authors concluded that the mild procedure is safe and provides long-term pain relief and improved mobility in patients with LSS.